Planning Regulatory Life Cycle Management of Pharmaceutical Products

A concise, decision-focused programme covering pharmaceutical life cycle regulation end to end.

📍 Abu Dhabi🗓️ 5 training days📚 4 modules🎓 Accredited certificate
5intensive training days
4scientific modules
8training sessions
32detailed points

Course Overview

Cost pressure and quality expectations on pharmaceutical life cycle regulation are rising at the same time. Accreditation bodies assess cycle regulation on documented evidence of consistent practice. They acquire practical criteria for judging when the health and pharmaceutical services discipline is working and when it is only appearing to. Sessions alternate between guided analysis of pharmaceutical life cycle regulation and supervised application. The level assumes working familiarity with the clinical service but no prior formal training in the practice within health and pharmaceutical services. Where cycle regulation is measured, it improves; where it is only discussed, it drifts. It establishes a shared vocabulary for pharmaceutical life cycle regulation so that teams can disagree productively about it. Progress on cycle regulation is usually lost in the gap between approval and execution. The programme closes with an action plan for the health and pharmaceutical services discipline that each participant writes for their own organisation.

Expected Learning Outcomes

01

Sequence improvements to pharmaceutical life cycle regulation so that each step makes the next one easier.

02

Plan staffing and rota cover appropriate to demand in cycle regulation.

03

Plan continuity of pharmaceutical life cycle regulation during surge, outbreak and emergency.

04

Recognise early indicators that cycle regulation is drifting away from its intended design.

05

Design a practical operating method for pharmaceutical life cycle regulation that fits the organisation's size and maturity.

06

Build informed consent and ethics practice into cycle regulation.

07

Design escalation for clinical deterioration detected through pharmaceutical life cycle regulation.

Who Should Attend

01

Hospital and health facility managers accountable for pharmaceutical life cycle regulation.

02

Pharmacists and pharmacy managers involved in cycle regulation.

03

Accreditation and compliance officers preparing evidence on pharmaceutical life cycle regulation.

04

Specialists advising senior management on cycle regulation.

05

Supply chain and biomedical staff supporting pharmaceutical life cycle regulation.

06

Managers of multi-site operations seeking consistency in cycle regulation.

Course Modules

01

Pharmaceutical life cycle regulation: supply, cold chain and availability

2 sessions · 8 points

Session 1Choosing indicators for pharmaceutical life cycle regulation that reflect outcome

  • Test the procedure for pharmaceutical life cycle regulation against a realistic scenario.
  • Prepare the summary of cycle regulation that senior management will read.
  • Establish the boundary of pharmaceutical life cycle regulation and record what sits outside it.
  • Set escalation thresholds for cycle regulation that work out of hours.

Session 2The evidence assessors will ask for on cycle regulation

  • Verify six months later that changes to pharmaceutical life cycle regulation have held.
  • Build medication safety checks into cycle regulation at the point of highest risk.
  • Confirm patient data handled within pharmaceutical life cycle regulation meets confidentiality obligations.
  • Establish who is informed, consulted and accountable in cycle regulation.
02

Cycle regulation: cost, efficiency and sustainability of the service

2 sessions · 8 points

Session 1Reviewing cycle regulation when nothing has gone wrong

  • Confirm the incident reporting route for pharmaceutical life cycle regulation is quick and non-punitive.
  • Arrange the handover of cycle regulation so capability survives staff changes.
  • Establish what evidence demonstrates pharmaceutical life cycle regulation is under control.
  • Draft the minimum viable clinical protocol for cycle regulation.

Session 2Auditing cycle regulation at the bedside, not in the binder

  • Reduce unwarranted variation in pharmaceutical life cycle regulation between shifts and sites.
  • Check that consent processes within cycle regulation are genuinely informed.
  • Set the review interval for pharmaceutical life cycle regulation and who attends.
  • Close the loop: confirm changes to cycle regulation improved the indicator they targeted.
03

Cycle regulation: infection prevention and patient safety

2 sessions · 8 points

Session 1What has to be agreed before work on cycle regulation starts

  • Write down the assumptions underpinning the approach to pharmaceutical life cycle regulation.
  • Map the clinical workflow for cycle regulation as it is actually performed.
  • Identify infection transmission risks created by pharmaceutical life cycle regulation and control them.
  • Apply structured root cause analysis to the last adverse event involving cycle regulation.

Session 2What to measure in pharmaceutical life cycle regulation and what to ignore

  • Distinguish symptoms from causes when pharmaceutical life cycle regulation underperforms.
  • Audit cycle regulation by observing practice, not by reading policy.
  • Define acceptance criteria for pharmaceutical life cycle regulation in advance.
  • Name a single owner for each element of cycle regulation.
04

Cycle regulation: regulation, licensing and accreditation evidence

2 sessions · 8 points

Session 1Keeping supply and cold chain reliable for cycle regulation

  • Select quality indicators for pharmaceutical life cycle regulation that measure outcome rather than activity.
  • Measure patient experience of cycle regulation and feed it back to the team.
  • Plan continuity of pharmaceutical life cycle regulation during surge and outbreak conditions.
  • Build the competence framework that supports cycle regulation.

Session 2Infection risk created by cycle regulation

  • Cost pharmaceutical life cycle regulation per episode and identify avoidable waste.
  • Identify where judgement in cycle regulation is legitimate and where it is not.
  • Assemble the accreditation evidence pack for pharmaceutical life cycle regulation.
  • Define escalation criteria for deterioration detected through cycle regulation.

Choose the package that suits you

Silver Package

At least 3 people

USD1,250
  • Workshop or Program Participation
  • Airport Transfers
  • Customized Badge
  • Expert Mentorship (Private Sessions)
  • Supervision & Secretarial Services
  • Accredited Certificate of Participation
  • Complete Training Kit
  • Coffee Break
  • Closing Ceremony

Gold Package

At least 3 people

USD1,850
  • 5-night stay in a 5-star hotel
  • Workshop or Program Participation
  • Airport Transfers
  • Customized Badge
  • Expert Mentorship (Private Sessions)
  • Supervision & Secretarial Services
  • Accredited Certificate of Participation
  • Complete Training Kit
  • Coffee Break
  • Closing Ceremony

Complete your registration

We will contact you within one business day to confirm.